InvestorsHub Logo
Followers 49
Posts 11207
Boards Moderated 0
Alias Born 06/15/2014

Re: couldbebetter post# 410399

Thursday, 06/08/2023 8:46:54 PM

Thursday, June 08, 2023 8:46:54 PM

Post# of 424759
I used to not have a very confident outlook concerning V wrt delaying, treating, or preventing AD. One of the main reasons was that AD is and is expected to explode in Japan. I was very confident in R-I results because of the low incidence of CVD in Japan (high consumption of EPA in the diet), and so thinking along the same lines, I was not confident that EPA would be very helpful in AD.

BUT I have changed my outlook. Here is an article outlining the rapid increase in AD coming the next years in Japan:

https://www.clinicaltrialsarena.com/comment/japan-will-fastest-growing-prevalent-cases-alzheimers/

BUT, the caveat is, that those larger numbers will be primarily because of the huge amount of aging Japanese, and aging is one of the big factors in AD. The other thing, that is not mention in the link above, but I have read about, is that the diet among the Japanese is changing. It could well be that although the geriatric population used to eat a diet high in EPA, that as they have aged and some of them in retirement homes, that they no longer eat as they used to. So all in all, I am hopeful that V can show some benefit to those susceptible to dementia and AD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News